This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
GERD, or gastroesophageal reflux disease, is a condition in which acid and other contents of the stomach move back up into the esophagus, causing a burning sensation in the chest. Symptoms of GERD can include heartburn, regurgitation, chest pain, difficulty swallowing, and an acidic taste in the mouth. In some cases, GERD can lead to complications such as esophagitis, Barrett’s esophagus, and even esophageal cancer. Esophagitis is an inflammation of the lining of the esophagus caused by the reflux of stomach acid. Symptoms include difficulty swallowing, chest pain, and heartburn. It can also cause scarring, narrowing of the esophagus, and bleeding. Barrett’s Esophagus is a condition in which the lining of the esophagus changes due to the reflux of stomach acid. This can lead to dysplasia, a pre-cancerous condition, and eventually to esophageal cancer. Symptoms of Barrett’s Esophagus include difficulty swallowing and heartburn. Esophageal cancer is a rare, but potentially serious complication of GERD.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States